Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer

Protgen

Status: Unknown

Conditions: Breast Cancer

Treatments: Device: Hsp90

Study type: Interventional

Funder types: Industry

Identifiers

NCT02324101

hsp90a2011-02

Details and patient eligibility

About

Detect plasma Hsp90α concentration of breast cancer patients, healthy volunteers, benign breast diseases patients

Full description

Detect plasma Hsp90α concentration of breast cancer patients, healthy volunteers, benign breast diseases patients, validate accuracy, specificity and sensitivity of Hsp90α kit.

Enrollment: 1,100 estimated patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• breast cancer patients, healthy volunteers, benign breast diseases patients

Exclusion criteria

• Patients who previously received radiotherapy

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

1,100 participants in 1 patient group

Breast cancer

Experimental group

Description:

Detect plasma Hsp90α concentration of breast cancer patients

Treatment:

Device: Hsp90